Medtronic's Micra leadless pacemaker passes the initial safety and efficacy endpoints at the 1-month mark of a global clinical trial.
from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1Katrbg
Cap comentari:
Publica un comentari a l'entrada